CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,064,408 | +28.3% | 75,772 | +4.8% | 0.05% | +23.8% |
| Q2 2023 | $1,608,475 | +19.9% | 72,291 | +9.5% | 0.04% | +10.5% |
| Q4 2022 | $1,341,394 | +205.6% | 66,046 | +285.6% | 0.04% | +153.3% |
| Q3 2022 | $439,000 | -67.7% | 17,129 | -70.0% | 0.02% | -75.4% |
| Q2 2022 | $1,358,000 | +10.8% | 57,105 | +4.9% | 0.06% | +5.2% |
| Q1 2022 | $1,226,000 | +26.3% | 54,447 | +11.0% | 0.06% | -3.3% |
| Q4 2021 | $971,000 | +302.9% | 49,065 | +301.1% | 0.06% | +215.8% |
| Q3 2021 | $241,000 | -77.6% | 12,232 | -80.2% | 0.02% | -72.5% |
| Q3 2020 | $1,077,000 | +144.8% | 61,875 | +136.8% | 0.07% | +122.6% |
| Q2 2020 | $440,000 | +214.3% | 26,130 | +125.1% | 0.03% | +287.5% |
| Q4 2019 | $140,000 | -82.5% | 11,608 | -80.6% | 0.01% | -84.0% |
| Q4 2018 | $800,000 | +288.3% | 59,868 | +308.0% | 0.05% | +233.3% |
| Q3 2018 | $206,000 | -30.2% | 14,672 | -21.9% | 0.02% | -25.0% |
| Q2 2018 | $295,000 | -59.0% | 18,789 | -57.0% | 0.02% | -60.0% |
| Q1 2018 | $719,000 | +255.9% | 43,688 | +137.4% | 0.05% | +92.3% |
| Q1 2017 | $202,000 | – | 18,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |